Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)
CovidSurg
1 other identifier
observational
1,000
1 country
1
Brief Summary
CovidSurg will capture real-world international data, to determine 30-day mortality in patients with COVID-19 infection who undergo surgery. This shared international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, ultimately improving their clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 25, 2020
CompletedFirst Posted
Study publicly available on registry
March 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedMay 12, 2020
May 1, 2020
9 months
March 25, 2020
May 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day mortality
Death up to 30-days post surgery
30 days
Secondary Outcomes (6)
7-day mortality
7 days post surgery
30-day reoperation
Up to 30-days post surgery
Postoperative ICU admission
Up to 30 days post surgery
Postoperative respiratory failure
Up to 30 days post surgery
Postoperative acute respiratory distress syndrome (ARDS)
Up to 30 days post surgery
- +1 more secondary outcomes
Study Arms (1)
Cohort 1
Patients with COVID-19 infection undergoing surgery
Interventions
Eligibility Criteria
Patients with COVID-19 infection who undergo surgery
You may qualify if:
- Patients undergoing ANY type of surgery in an operating theatre, this includes obstetrics
- AND
- \- The patient had COVID-19 infection either at the time of surgery or within 30 days of surgery, based on
- (i) positive COVID-19 lab test or computed tomography (CT) chest scan
- (ii) clinical diagnosis (no COVID-19 lab test or CT chest performed)
You may not qualify if:
- If COVID-19 infection is diagnosed \>30 days after discharge, the patient should not be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital del Henares
Madrid, Spain
Related Publications (2)
COVIDSurg Collaborative. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study. BMJ Open. 2021 Nov 30;11(11):e050830. doi: 10.1136/bmjopen-2021-050830.
PMID: 34848515DERIVEDSeeliger B, Philouze G, Cherkaoui Z, Felli E, Mutter D, Pessaux P. Acute abdomen in patients with SARS-CoV-2 infection or co-infection. Langenbecks Arch Surg. 2020 Sep;405(6):861-866. doi: 10.1007/s00423-020-01948-2. Epub 2020 Jul 27.
PMID: 32720012DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2020
First Posted
March 26, 2020
Study Start
January 1, 2020
Primary Completion
September 30, 2020
Study Completion
September 30, 2020
Last Updated
May 12, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
No individual participant data will be available to other researchers